|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent NOVN insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why NOVN insider buys are important for investors to follow.
Date | Insider | Price | Amount |
3-25-2022 Insider Buy |
James L. Bierman Director |
$3.54
CAGR »
|
$7,090.00 2,000 shares |
3-17-2022 Insider Buy |
John W. Palmour Director |
$3.34
CAGR »
|
$33,390.00 10,000 shares |
3-26-2021 Insider Buy |
Paula B. Stafford President and CEO |
$1.43
CAGR »
|
$100,100.00 70,000 shares |
5-29-2019 Insider Buy |
G. Kelly Martin Chief Executive Officer |
$1.97
CAGR »
|
$2,955.00 1,500 shares |
5-24-2019 Insider Buy |
John W. Palmour Director |
$2.20
CAGR »
|
$44,000.00 20,000 shares |
5-28-2019 Insider Buy |
G. Kelly Martin Chief Executive Officer |
$2.15
CAGR »
|
$7,525.00 3,500 shares |
5-22-2019 Insider Buy |
Robert Alexander Ingram Director |
$2.21
CAGR »
|
$110,500.00 50,000 shares |
5-21-2019 Insider Buy |
W. Kent Geer Director |
$1.90
CAGR »
|
$9,500.00 5,000 shares |
9-26-2018 Insider Buy |
G. Kelly Martin Chief Executive Officer |
$2.73
CAGR »
|
$27,300.00 10,000 shares |
8-22-2018 Insider Buy |
John W. Palmour Director |
$2.66
CAGR »
|
$53,200.00 20,000 shares |
8-21-2018 Insider Buy |
G. Kelly Martin Chief Executive Officer |
$2.71
CAGR »
|
$81,300.00 30,000 shares |
8-29-2017 Insider Buy |
Robert Alexander Ingram Director |
$4.57
CAGR »
|
$54,809.25 12,000 shares |
8-23-2017 Insider Buy |
John W. Palmour Director |
$3.99
CAGR »
|
$47,880.00 12,000 shares |
9-26-2016 Insider Buy |
Life Sciences Holdings Ltd Malin >10% Owner |
$11.00
CAGR »
|
$8,800,000.00 800,000 shares |
Also See: Institutional Holders of NOVN
Also See: SEC filings
Below we present the annualized performance delivered by NOVN stock since 3-25-2022 (the date of the most recent
insider purchase). The performance of the investment from the time NOVN insider buying occurred is the ultimate
test of whether insiders were right about NOVN being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/28/2022 |
|
End date: |
07/25/2023 |
|
Start price/share: |
$3.52 |
|
End price/share: |
$0.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.33% |
|
Average Annual Total Return: |
-93.49% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$267.16 |
|
Years: |
1.33 |
|
NOVN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent NOVN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NOVN
|
|